Status
Conditions
Treatments
About
This study explores a safe and effective new approach to assisting children with Global Developmental Delay (GDD) and comorbid language disorders. Conducted at Xiangxi Autonomous Prefecture People's Hospital, the study will recruit approximately 50 children aged 2 to 5 years. Participants will be randomly assigned to one of two groups: one receiving personalized language training combined with non-invasive, painless repetitive Transcranial Magnetic Stimulation (rTMS) to activate language regions of the brain, and a control group receiving personalized training alongside sham stimulation for comparative analysis. The study spans one month, including a two-week intervention period followed by a two-week follow-up to evaluate the efficacy and sustainability of the combined therapy. This study has been rigorously reviewed and approved by the hospital's Ethics Committee.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
1. history of epilepsy or convulsive seizures. 2. having metal implants in the skull (e.g. aneurysm clips, metal stents, etc.) and electronic devices such as pacemakers and cochlear implants in the body.
3. other serious neurological conditions that may affect language function (e.g., cerebral palsy, progressive neurological disorders, etc.).
4. have a diagnosis of Autism Spectrum Disorder (ASD). 5. have a severe hearing or visual impairment. 6. participation in other clinical trials that may affect speech function. 7. breakage or infection at the scalp treatment site. 8.the fontanelle has not yet closed. 9. previous rTMS treatment in the last 3 months. 10. developmental quotient < 40 in any developmental domains; other circumstances that prevented cooperation with the study.
Primary purpose
Allocation
Interventional model
Masking
50 participants in 2 patient groups
Loading...
Central trial contact
Fangkun Liu, MD, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal